C.Q. Pharmaceutical Holding Co., Ltd. - Laporan Laba Rugi (TTM)

C.Q. Pharmaceutical Holding Co., Ltd.
CN ˙ SZSE
CN¥ 5.21 ↑0.01 (0.19%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi C.Q. Pharmaceutical Holding Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 39,096 45,220 52,016 58,266 61,022 62,521 63,938 65,084 66,833 67,829 71,571 75,869 75,682 78,397 78,401 77,462 79,706 80,562 81,549 81,971
Change (%) 15.66 15.03 12.01 4.73 2.46 2.27 1.79 2.69 1.49 5.52 6.01 -0.25 3.59 0.01 -1.20 2.90 1.07 1.23 0.52
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 35,534 41,012 47,291 52,968 55,452 56,817 58,133 59,298 61,093 62,038 65,443 69,428 69,310 72,162 72,270 71,543 73,793 74,641 75,665 76,122
Change (%) 15.42 15.31 12.00 4.69 2.46 2.32 2.00 3.03 1.55 5.49 6.09 -0.17 4.11 0.15 -1.01 3.14 1.15 1.37 0.60
% of Revenue 90.89 90.70 90.92 90.91 90.87 90.88 90.92 91.11 91.41 91.46 91.44 91.51 91.58 92.05 92.18 92.36 92.58 92.65 92.78 92.86
Gross Operating Profit 3,562 4,207 4,726 5,298 5,570 5,703 5,806 5,786 5,740 5,791 6,128 6,441 6,372 6,235 6,132 5,918 5,914 5,921 5,884 5,849
Change (%) 18.13 12.32 12.11 5.13 2.40 1.79 -0.33 -0.81 0.90 5.82 5.10 -1.07 -2.14 -1.67 -3.48 -0.08 0.12 -0.62 -0.60
% of Revenue 9.11 9.30 9.08 9.09 9.13 9.12 9.08 8.89 8.59 8.54 8.56 8.49 8.42 7.95 7.82 7.64 7.42 7.35 7.22 7.14
SG&A 2,042 2,319 2,621 2,921 3,149 3,360 3,476 3,529 3,242 3,423 3,546 3,742 4,163 4,066 4,167 4,166 4,179 4,499 4,455 4,453
Change (%) 13.55 13.00 11.46 7.81 6.70 3.45 1.52 -8.13 5.57 3.60 5.54 11.24 -2.33 2.49 -0.03 0.33 7.64 -0.97 -0.06
% of Revenue 5.22 5.13 5.04 5.01 5.16 5.37 5.44 5.42 4.85 5.05 4.95 4.93 5.50 5.19 5.32 5.38 5.24 5.58 5.46 5.43
R&D 4 3 6 5 5 10 7 7 7 3 5 4 6 0 -1 7 5 0 0 -7
Change (%) -25.63 120.89 -11.52 4.52 83.95 -31.76 -1.50 4.43 -54.10 43.91 -16.91 43.92 -93.12 -338.54 -830.73 -18.18 -94.17 -29.02 -3,026.71
% of Revenue 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.00 -0.00 0.01 0.01 0.00 0.00 -0.01
OpEx 37,677 43,458 50,054 56,049 58,770 60,343 61,777 62,988 64,502 65,652 69,185 73,382 73,674 76,441 76,648 75,940 78,191 79,329 80,320 80,743
Change (%) 15.34 15.18 11.98 4.86 2.68 2.38 1.96 2.40 1.78 5.38 6.07 0.40 3.76 0.27 -0.92 2.97 1.46 1.25 0.53
% of Revenue 96.37 96.10 96.23 96.19 96.31 96.52 96.62 96.78 96.51 96.79 96.67 96.72 97.35 97.50 97.76 98.04 98.10 98.47 98.49 98.50
Operating Income 1,419 1,762 1,962 2,217 2,251 2,177 2,161 2,096 2,331 2,177 2,386 2,487 2,008 1,957 1,753 1,522 1,515 1,232 1,229 1,227
Change (%) 24.11 11.39 12.98 1.55 -3.29 -0.74 -3.02 11.21 -6.62 9.59 4.26 -19.25 -2.58 -10.40 -13.18 -0.46 -18.66 -0.25 -0.18
% of Revenue 3.63 3.90 3.77 3.81 3.69 3.48 3.38 3.22 3.49 3.21 3.33 3.28 2.65 2.50 2.24 1.96 1.90 1.53 1.51 1.50
Interest Expense -586 -676 -835 -952 -1,091 -1,106 -1,102 -1,119 -1,093 -1,123 -1,203 -1,260 -1,336 -1,340 -1,269 -1,249 -1,177 -1,138 -1,053 -960
Change (%) 15.25 23.57 14.02 14.66 1.31 -0.28 1.50 -2.32 2.77 7.05 4.73 6.09 0.29 -5.31 -1.56 -5.77 -3.33 -7.48 -8.77
% of Revenue -1.50 -1.49 -1.60 -1.63 -1.79 -1.77 -1.72 -1.72 -1.64 -1.66 -1.68 -1.66 -1.77 -1.71 -1.62 -1.61 -1.48 -1.41 -1.29 -1.17
Net Income 755 884 880 1,022 954 1,005 1,038 969 1,104 952 1,006 1,065 690 625 562 349 399 283 305 327
Change (%) 17.18 -0.53 16.22 -6.68 5.38 3.22 -6.67 13.94 -13.72 5.69 5.82 -35.20 -9.49 -10.10 -37.84 14.38 -29.12 7.87 7.18
% of Revenue 1.93 1.96 1.69 1.75 1.56 1.61 1.62 1.49 1.65 1.40 1.41 1.40 0.91 0.80 0.72 0.45 0.50 0.35 0.37 0.40

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista